Teprotumumab for Optic Neuropathy and Thyroid Eye Disease

In this interview, Drs. Julian Perry and Catherine Hwang discuss the use of teprotumumab for optic neuropathy and thyroid eye disease. A recent case study involving 2 patients with TED and optic neuropathy showed that teprotumumab infusions led to improvements in optic neuropathy. More data will be needed to confirm these findings. 

Relevant Financial Disclosures: None